The Most Studied Mitochondrial Compounds in 2026: MDPs, Cofactors & Beyond

The Most Studied Mitochondrial Compounds in 2026: MDPs, Cofactors & Beyond

Peps Research
Published on: 30/03/2026

Complete research guide to mitochondria-derived peptides: MOTS-c, Humanin, SS-31, SHLPs, NAD+, and Methylene Blue. Citations from JCI, PNAS, NEJM. RUO only.

Peptide Research
MOTS-c vs NAD+: Two Different Approaches to Mitochondrial Research

MOTS-c vs NAD+: Two Different Approaches to Mitochondrial Research

Peps Research
Published on: 25/03/2026

How MOTS-c and NAD+ target mitochondrial aging from different directions. Published research from Cell Metabolism, Science, and Harvard/MIT reviewed. RUO only.

Peptide Research
MOTS-c vs Retatrutide: Mechanisms, Research, and What Scientists Are Studying

MOTS-c vs Retatrutide: Mechanisms, Research, and What Scientists Are Studying

Peps Research
Published on: 18/03/2026

Comparing MOTS-c mitochondrial peptide and Retatrutide triple agonist mechanisms in metabolic research. NEJM, Lancet, Cell Metabolism citations. RUO only.

Peptide Research
BPC-157 and Inflammatory Bowel Disease: What the Preclinical Research Shows

BPC-157 and Inflammatory Bowel Disease: What the Preclinical Research Shows

Peps Research
Published on: 11/03/2026

30+ years of BPC-157 preclinical research in IBD, Crohn's disease and ulcerative colitis models. Phase II clinical trial data reviewed. For laboratory research only.

Peptide Research